IgA anti-B2GP1 has been shown to be strongly associated with DVT and stroke (10) and the thrombogenic effects of IgA anti-β2GP1 antibodies in vitro and in vivo animal models has been shown (11). Here, CD79A is linked to deep vein thrombosis.